These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31065073)

  • 21. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
    Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapy.
    Zur Y; Rosenfeld L; Keshelman CA; Dalal N; Guterman-Ram G; Orenbuch A; Einav Y; Levaot N; Papo N
    PLoS Biol; 2018 Aug; 16(8):e2002979. PubMed ID: 30142160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors.
    Yamazaki H; Kunisada T; Yamane T; Hayashi SI
    Exp Hematol; 2001 Jan; 29(1):68-76. PubMed ID: 11164107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
    Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M-CSF mediates TNF-induced inflammatory osteolysis.
    Kitaura H; Zhou P; Kim HJ; Novack DV; Ross FP; Teitelbaum SL
    J Clin Invest; 2005 Dec; 115(12):3418-27. PubMed ID: 16294221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
    Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro.
    Marahleh A; Kitaura H; Ishida M; Shima K; Kishikawa A; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Nara Y; Mizoguchi I
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30933072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.
    Shevde NK; Bendixen AC; Dienger KM; Pike JW
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7829-34. PubMed ID: 10869427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts.
    Sakai H; Chen Y; Itokawa T; Yu KP; Zhu ML; Insogna K
    Bone; 2006 Dec; 39(6):1290-301. PubMed ID: 16950670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Participation of protein kinase C beta in osteoclast differentiation and function.
    Lee SW; Kwak HB; Chung WJ; Cheong H; Kim HH; Lee ZH
    Bone; 2003 Mar; 32(3):217-27. PubMed ID: 12667549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering a monomeric variant of macrophage colony-stimulating factor (M-CSF) that antagonizes the c-FMS receptor.
    Zur Y; Rosenfeld L; Bakhman A; Ilic S; Hayun H; Shahar A; Akabayov B; Kosloff M; Levaot N; Papo N
    Biochem J; 2017 Jul; 474(15):2601-2617. PubMed ID: 28655719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts.
    Kalbasi Anaraki P; Patecki M; Tkachuk S; Kiyan Y; Haller H; Dumler I
    J Bone Miner Res; 2015 Feb; 30(2):379-88. PubMed ID: 25196912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of protein kinase C-δ protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorption.
    Khor EC; Abel T; Tickner J; Chim SM; Wang C; Cheng T; Ng B; Ng PY; Teguh DA; Kenny J; Yang X; Chen H; Nakayama KI; Nakayama K; Pavlos N; Zheng MH; Xu J
    PLoS One; 2013; 8(8):e70815. PubMed ID: 23951014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage.
    Gupta N; Barhanpurkar AP; Tomar GB; Srivastava RK; Kour S; Pote ST; Mishra GC; Wani MR
    J Immunol; 2010 Aug; 185(4):2261-72. PubMed ID: 20644169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functions of the M-CSF receptor on osteoclasts.
    Yang S; Zhang Y; Rodriguiz RM; Ries WL; Key LL
    Bone; 1996 Apr; 18(4):355-60. PubMed ID: 8726394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
    El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
    Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.